Mar 15, 2024 / Reports March 2024 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 15, 2024 / Chapters Chapter 12: The Medicare Advantage program: Status report (March 2024 Report) Research Areas: Beneficiaries and Coverage, Private Plans, Quality
Mar 15, 2024 / Chapters Chapter 14: Mandated report: Dual-eligible special needs plans (March 2024 Report) Research Areas: Beneficiaries and Coverage
Jan 22, 2024 / Data Book January 2024 MedPAC and MACPAC Data Book: Beneficiaries Dually Eligible for Medicare and Medicaid Research Areas: Beneficiaries and Coverage, Private Plans
Nov 02, 2023 / Presentations Mandated report: Dual-eligible special needs plans Research Areas: Delivery System Reforms, Medicare Spending and Financing, Private Plans
Mar 15, 2023 / Chapters Chapter 11: The Medicare Advantage program: Status report (March 2023 Report) Research Areas: Beneficiaries and Coverage, Private Plans, Quality
Mar 15, 2022 / Chapters Chapter 12: The Medicare Advantage program: Status report and mandated report on dual-eligible special needs plans (March 2022 Report) Research Areas: Beneficiaries and Coverage, Private Plans, Quality
Jun 15, 2021 / Press Releases MedPAC releases June 2021 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jun 15, 2021 / Reports June 2021 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Apr 03, 2020 / Comment Letters MedPAC comment on CMS’s proposed rule on contract year 2021 and 2022 policy and technical changes to Medicare Advantage and Part D Research Areas: Drugs, Devices, and Tests, Private Plans, Quality